Asymmetric addition of phenylzinc reagents to C-alkynyl nitrones. Enantiomeric enhancement by a product-like additive by Wei Weilin et al.
Asymmetric addition of phenylzinc reagents to
C-alkynyl nitrones. Enantiomeric enhancement
by a product-like additive












To create your abstract, type over the instructions in the template box below.
Fonts or abstract dimensions should not be changed or altered.
Asymmetric Addition of Phenylzinc Reagents 
to C-Alkynyl Nitrones. Enantiomeric Enhancement by a
Product-like Additive
Weilin Wei, Yoshihira Hamamoto, Yutaka Ukaji,* Katsuhiko Inomata*
Division of Material Sciences, Graduate School of Natural Science and Technology, Kanazawa University, 




















up to 92% ee(1.2 eq.)
Leave this area blank for abstract info.
* Graphical Abstract
Tetrahedron: Asymmetry 1
   Asymmetric Addition of Phenylzinc Reagents to C-Alkynyl Nitrones. 
Enantiomeric Enhancement by a Product-like Additive
Weilin Wei, Yoshihira Hamamoto, Yutaka Ukaji,* and Katsuhiko Inomata*
Division of Material Sciences, Graduate School of Natural Science and Technology, Kanazawa University, 
Kakuma, Kanazawa, Ishikawa 920-1192, Japan
(Received; E-mail: inomata@cacheibm.s.kanazawa-u.ac.jp)
Abstract—Asymmetric addition of diphenylzinc to C-alkynyl nitrones was achieved by utilizing di(t-butyl) (R,R)-tartrate as 
a chiral auxiliary to afford the corresponding optically active (S)-N-(1-phenyl-3-substituted prop-2-ynyl)hydroxylamines. By 
the addition of a product-like additive, enantiomeric enhancement was observed.  A mixed zinc reagent, PhZnMe, improved 
enantioselection affording the hydroxylamines up to 92% ee.  
  © 2008 Elsevier Science. All rights reserved
1. Introduction
Chiral amines are synthetically important target
compounds, since they are found in natural products, 
pharmaceuticals, and other bioactive molecules.1 For 
example, chiral benzylic amines are found in such 
biologically active compounds and their building blocks.2
One of the most attractive approaches to the syntheses of 
benzylic amines is the enantioselective addition of 
phenylmetal reagents to imine derivatives.3,4  Although 
various methods for the enantioselective synthesis of chiral 
benzylic amines are known including reduction and 
alkylation of aromatic imines, direct asymmetric addition 
of phenyl reagents to C=N bond is still one of the 
challenging problems especially in terms of availability of 
chiral auxiliaries.  Very recently we have reported an 
enantioselective nucleophilic addition of alkynylzinc 
reagents to nitrones by utilizing a tartaric acid ester as a 
chiral auxiliary and unprecedented enantiomeric
*Corresponding author. Tel.: 81-76-264-5700; fax: 81-76-
264-5742; e-mail: inomata@cacheibm.s.kanazawa-u.ac.jp
enhancement by a racemic product-like additive was 
realized.5  Herein, we wish to describe an enantioselective 
addition of phenylzinc reagents to acyclic nitrones bearing 
an alkynyl substituent on the carbon utilizing the tartaric 
acid ester as a chiral auxiliary to produce N-(1-phenyl-3-
substituted prop-2-ynyl)hydroxylamines.  The enantiomeric 
enhancement by the addition of a product-like additive was 
again observed.



































An asymmetric addition reaction of diphenylzinc to N-
benzyl C-alkynyl nitrone 2a was first examined (Table 1).   To 
a solution of a 1.0 equivalent of bis(methylzinc) salt of di(t-
butyl) (R,R)-tartrate 1, prepared in situ from 1.0 equivalent of 
di(t-butyl) (R,R)-tartrate [(R,R)-DTBT] and 2.0 equivalents of 
dimethylzinc in CH2Cl2, diphenylzinc (X  Ph) and nitrone 2a
were successively added at 0 C (eq. 1, m = 1.0, n = 0). After 
usual work up, the corresponding N-
(propargylic)hydroxylamine 3a was obtained in 53% yield 
with enantioselectivity of 70% ee (Entry 1).  The addition 
predominantly occurred from si-face of the nitrone 2a, and the 
sense of the enantiofacial differentiation was same as that in 
the previous our addition reaction of alkynylzinc reagents to 
C-(phenyl-substituted) nitrones.5 When the reaction 
temperature was increased to 25 C or 40 C, the reaction 
proceeded smoothly to give the desired product 3a with 
enantioselectivities of 76% ee and 79% ee, respectively
(Entries 2 and 3).  Previously, we observed the enantiomeric 
enhancement by a product-like additive in the addition of 
alkynylzinc reagents.5  Thus, the effect of the addition of a 
product-like additive 4, prepared in situ from 0.2 equivalent of 
racemic N-benzyl-N-[1- (4-methoxyphenyl)-3-phenylprop-2-
ynyl]hydroxylamine and 0.2 equivalent of dimethylzinc, was 
also investigated in the present reaction at 0 C, 25 C and 40 
C, respectively (eq. 1, m = 1.0, n = 0.2).5a To our delight, the 
enantioselectivity was remarkably enhanced, respectively 
(Entries 4-6).  When the reaction was carried out at 25 C and 
40 C, 3a was obtained with high enantioselectivity of 88% ee.    
The effect of the solvent was also investigated for further 
optimization at 25 C. (Entries 5, 7-10).  Although the 
enantioselectivity did not remarkably change depending on the 
solvent used, higher yield was resulted in CHCl3. When 0.2 
equivalent of 1 was used, enantioselectivity was not 
satisfactory (Enrty 11). However, enantiomeric enhancement
was still observed by addition of the product-like additive 4 to 
give 3a with improved enantioselectivity (Enrty 12).  
Finally it was found that utilization of a mixed zinc species 
PhZnMe, prepared in situ from Ph2Zn and Me2Zn,
6 achieved
the highest enantioselectivity of 92% ee (Entry 14).
Asymmetric additions of phenylzinc reagents to
several other nitrones 2 were performed (eq. 2) to furnish 
the corresponding N-(propargylic)hydroxylamines 3 with 
high enantioselectivities (Table 2).  It was confirmed that 
the addition of the product-like additive 4 was effective to 
improve enantioselectivity as shown in the column of n =
0.2 in Table 2.  Not only in the case of C-(aryl-substituted
alkynyl) nitrones 2a-c, but also in the case of C-(alkyl-
substituted alkynyl) nitrone 2d, the enantiomeric excess 
was remarkably enhanced in the presence of additive 4.  
Furthermore, higher enantioselectivity was accomplished 
































































































































aEnantiomer ratios were determined by HPLC analysis (Daicel Chiralcel OD-H).
bPhZnMe was prepared in situ from 0.5 eq. of Ph2Zn and 0.5 eq. of Me2Zn.






























It was now confirmed that enantiomeric 
enhancement occurrs in the preparation of 3 by both the 
phenylation of C-alkynyl nitrones and alkynylation of C-
aromatic nitrones.5 To scope such an intriguing
enantiomeric enhancement,7   asymmetric phenylation of a
C-alkenyl nitrone 5 was next examined.  The addition 
reaction was sluggish to afford the corresponding N-
(allylic)hydroxylamine 6 with poor enantioselectivity,  
however, the enantioselectivity was also enhanced to 49% 




























n = 0.2; 76%, 49% ee
n = 0; 88%, 25% ee
(3)
3. Conclusion
As described above, the asymmetric addition of 
phenylzinc reagents to C-alkynyl nitrones have been 
developed utilizing tartaric acid ester as a chiral auxiliary.  
By the addition of a product-like substrate, the high
enantioselectivities were realized.   Furthermore, the 
enantiomeric enhancement by the addition of N-
(propargylic)hydroxylamine derivative 4 was also achieved 
in the case of C-alkenyl nitrone.  Further investigation for 
the present peculiar enantiomeric enhancement by the 
product-like additive is now in progress in our laboratory.   
4. Experimental
4.1 General
All of the melting points were determined by a micro 
melting apparatus (Yamagimoto-Seisakusho) and 
uncorrected.  The 1H NMR spectra were recorded on a 
JEOL Lambda 400 and a JEOL Lambda 300 spectrometers.  
The chemical shifts were determined in the -scale relative 
to tetramethylsilane (= 0) as an internal standard.  The IR 
spectra were measured by JASCO FT/IR-230 spectrometer.  
The specific optical rotations were recorded on JASCO 
DIP-370 spectrometer.  CHCl3 was treated with Merck’s 
aluminum oxide 90 active basic (0.063–0.200 mm, activity 
stage I, Art. 101076) and dried over MS 4A just before use.  
Et2O was freshly distilled from sodium diphenylketyl.  All 
other solvents were distilled and stored over drying agents.  
Flash column chromatography and thin-layer 
chromatography (TLC) were performed on Cica-Merck’s 
silica gel 60 (No. 9385-5B) and Merck’s silica gel 60 PF254
(Art. 107749), respectively.   
4.2 Preparation of Aldehydes
Phenylpropynal was prepared according to the 
procedure described in reference 9. Other aldehydes were 
prepared in a similar manner.
Phenylpropynal:9 An oil, IR (neat) 3297, 3061, 2856, 
2189, 1660, 1489, 1444, 1388, 1261, 1174, 1027, 1002, 978, 
758, 688 cm–1; 1H NMR (CDCl3)  = 7.36-7.40 (m, 2H), 
7.44-7.49 (m, 1H), 7.52-7.64 (m, 2H), 9.47 (s, 1H, CHO); 
HRMS (FAB+), Found: m/z 131.04970. Calcd for C9H7O:
(M+ + H), 131.05015.
p-Tolylpropynal: An oil, IR (neat) 3295, 3033, 2922, 2856, 
2185, 1657, 1605, 1508, 1448, 1408, 1385, 1266, 1180, 
1020, 982, 817, 711 cm–1; 1H NMR (CDCl3)   = 2.39 (s, 
3H, CH3), 7.20 (d, J = 8.06 Hz, 2H), 7.49 (d, J = 8.06 Hz, 
2H), 9.41 (s, 1H, CHO); HRMS (FAB+), Found: m/z
145.06581. Calcd for C10H9O: (M
+ + H), 145.06535.
(4-Bromophenyl)propynal: Mp 95–97 °C (from 
hexane/AcOEt; unstable on storage); IR (KBr) 3283, 3087, 
2922, 2890, 2191, 1654, 1581, 1475, 1392, 1264, 1067, 





































aEnantiomer ratio was determined by HPLC analysis (Daicel Chiralcel OD-H).
bEnantiomer ratio was determined by HPLC analysis (Daicel Chiralcel OJ-H).
cPhZnMe was prepared in situ from 0.5 eq. of Ph2Zn and 0.5 eq. of Me2Zn.
Table 2. Asymmetric additon of phenylzinc regents to nitrones 2
























1009, 988, 822, 764 cm–1; 1H NMR (CDCl3)  = 7.46 (d, J
= 8.61 Hz, 2H), 7.56 (d, J = 8.61 Hz, 2H), 9.41 (s, 1H, 
CHO); HRMS (FAB+), Found: m/z 208.96006. Calcd for 
C9H6OBr: (M
+ + H), 208.96020.
Non-2-ynal: An oil, IR (neat) 2931, 2859, 2201, 1671, 
1457, 1387, 1226, 1137, 824, 790, 726 cm–1; 1H NMR 
(CDCl3)  = 0.88 (t, J = 7.14 Hz, 3H, CH3), 1.31 (m, 4H, 
(CH2)2), 1.39 (quin, J = 7.14 Hz, 2H, CH2), 1.60 (quin, J = 
7.14 Hz, 2H, CH2), 2.41 (t, J = 7.14 Hz, 2H, C≡CCH2), 
9.17 (s, 1H, CHO); HRMS (FAB+), Found: m/z 139.11263. 
Calcd for C9H15O: (M
+ + H), 139.11230.
4.3 Preparation of Nitrones
(Z)-1-Phenyl-N-(3-phenylprop-2-
ynylidene)methanamine Oxide (2a): To a solution of 
phenylpropynal (262 mg, 2.0 mmol) in CH2Cl2 (3 ml) with 
MS 3A (342 mg) was added a CH2Cl2 (3 ml) solution of N-
(benzyl)hydroxylamine (246 mg, 2.0 mmol) at 0 °C under 
an argon atmosphere.  The reaction mixture was stirred at 
0 °C overnight.  Then the solvent was removed in vacuo 
and the residue was partitioned between ethyl acetate and 
water.  The organic extract was washed successively with 
water, brine, and dried over sodium sulfate.  After 
evaporation of the solvent, the residue was separated by 
silica gel [treated with 10% (w/w) water in advance to 
deactivate] column chromatography (eluted with CHCl3) to 
afford 2a (170 mg) in 36% yield. The nitrone was so labile 
that it was partially decomposed during purification even 
by treatment with deactivated silica gel.  An oil, IR (neat) 
3062, 3030, 2923, 2215, 1654, 1578, 1541, 1495, 1451, 
1238, 1178, 1072, 1027, 754, 697 cm–1; 1H NMR (CDCl3) 
 = 5.37 (s, 2H, CH2Ph), 7.10 (s, 1H, ArHC=N), 7.29-7.39 
(m, 6H), 7.47-7.55 (m, 4H); HRMS (FAB+), Found: m/z
236.10799. Calcd for C16H14NO: (M
+ + H), 236.10754.
In a similar manner, nitrones 2b-2d were prepared 
from the corresponding aldehydes and N-
(benzyl)hydroxylamine. 
(Z)-1-Phenyl-N-(3-p-tolylprop-2-
ynylidene)methanamine Oxide (2b): An oil, IR (neat) 
3029, 2921, 2188, 1655, 1606, 1541, 1507, 1454, 1240, 
1178, 816, 753, 698 cm–1; 1H NMR (CDCl3)  = 2.39 (s, 
3H, CH3), 5.31 (s, 2H, CH2Ph), 7.11 (s, 1H, ArHC=N), 
7.20 (d, J = 8.01 Hz, 2H), 7.38 (d, J = 8.01 Hz, 2H), 7.30-
7.38 (m, 3H), 7.53-7.40 (m, 2H); HRMS (FAB+), Found:
m/z 250.12306. Calcd for C17H16NO: (M
+ + H), 250.12319.
(Z)-1-Phenyl-N-[3-(4-bromophenyl)prop-2-
ynylidene]methanamine Oxide (2c): Mp 90–91 °C (from 
hexane/AcOEt), IR (KBr) 3060, 3029, 2922, 2186, 1640, 
1584, 1536, 1485, 1452, 1395, 1355, 1290, 1241, 1173, 
1071, 1008, 952, 824, 771, 736, 697 cm–1; 1H NMR 
(CDCl3)  = 5.31 (s, 2H, CH2Ph), 6.19 (s, 1H, ArHC=N), 
7.32-7.41 (m, 4H), 7.50-7.54 (m, 5H); HRMS (FAB+), 
Found: m/z 314.01786. Calcd for C16H13NOBr: (M
+ + H), 
314.01805.
(Z)-1-Phenyl-N-(non-2-ynylidene)methanamine Oxide 
(2d): An oil, IR (neat) 3030, 2928, 2857, 2232, 1654, 1496, 
1455, 1353, 1078, 1028, 754, 698 cm–1; 1H NMR (CDCl3) 
 = 0.89 (t, J = 7.14 Hz, 3H, CH3), 1.35 (m, 4H, (CH2)2), 
1.43 (quin, J = 7.14 Hz, 2H, CH2), 1.59 (quin, J = 7.14 Hz,
2H, CH2), 2.50 (t, J = 7.14 Hz, 2H, C≡CCH2), 5.21 (s, 2H, 
CH2Ph), 6.89 (s, 1H, ArHC=N), 7.30-7.39 (m, 3H), 7.40-
7.56 (m, 2H); HRMS (FAB+), Found: m/z 244.16954. 
Calcd for C16H22NO: (M
+ + H), 244.17014.
(Z)-1-Phenyl-N-[(E)-3-phenylallylidene]methanamine 
Oxide (5): To a solution of cinnamaldehyde (925 mg, 7.0
mmol) in CH2Cl2 (4.5 ml) was added a CH2Cl2 (4.5 ml) 
solution of N-(benzyl)hydroxylamine (865 mg, 7.0 mmol)
at 25 °C under an argon atmosphere.  The reaction mixture 
was stirred at 0 °C overnight.  Then the solvent was 
removed in vacuo and the residue was recrystallized from 
hexane/AcOEt to give the nitrone 5 (1.229 g) in 74% yield. 
Mp 124–125 °C (from hexane/AcOEt); IR (KBr) 3051, 
1545, 1494, 1457, 1424, 1347, 1319, 1291, 1199, 1177, 
1122, 1072, 1026, 961, 941, 915, 861, 821, 764, 747, 700 
cm–1; 1H NMR (CDCl3)  = 4.96 (s, 2H, CH2Ph), 6.94 (d, J
= 16.34 Hz, 1H), 7.21 (d, J = 9.76 Hz, 1H), 7.28-7.36 (m, 
3H), 7.38–7.50 (m, 8H). Found: C, 81.00; H, 6.37; N, 
5.90%. Calcd for C16H15NO: C, 80.98; H, 6.37; N, 5.90%.
4.4 Preparation of N-benzyl-N-[1-(4-methoxyphenyl)-3-
phenylprop-2-ynyl]hydroxylamine:  To a toluene (9 ml) 
solution of phenyl acetylene (337 mg, 3.3 mmol) was 
added dimethylzinc (3.3 ml of 1.0 M solution in hexane, 
3.3 mmol) at 0 °C under argon atmosphere, and the mixture 
was stirred for 30 min.  To the solution, a toluene (9 ml)
solution of N-(4-methoxybenzylidene)-1-
phenylmethanamine oxide (732 mg, 3.0 mmol) was added.
The resulting solution was stirred at 0 ºC for 14 h and
quenched by addition of a saturated aq. NaHCO3 solution.  
After filtration of the precipitate, the filtrate was extracted 
with AcOEt.  The combined extracts were washed with 
brine, dried over Na2SO4, and condensed under reduced 
pressure.  The residue was separated by TLC on SiO2 to 
isolate the corresponding hydroxylamine (hexane/AcOEt =
3/1) in 97% yield (1.00 g). Mp 116–117 °C (from 
hexane/AcOEt), IR (KBr) 3235, 2924, 1608, 1509, 1489, 
1456, 1333, 1303, 1246, 1172, 1077, 1033, 801, 753, 699, 
690 cm–1; 1H NMR (CDCl3)  = 3.81 (s, 3H, OCH3), 3.97
(d, J = 13.06 Hz, 1H, CH2Ph), 4.06 (d, J = 13.06 Hz, 1H, 
CH2Ph), 4.90 (s, 1H, OH), 4.97 (s, 1H, ArCHNBn), 6.91 (d, 
J = 8.61 Hz, 2H) 7.28-7.41 (m, 8H), 7.54-7.58 (m, 4H); 
HRMS (FAB+), Found: m/z 344.1650. Calcd for C23H22NO:
(M+ + H), 344.1652.
4.5 Asymmetric Phenylation
Representative Procedure for Asymmetric Phenylation 
of N-Benzyl C-Alkynyl Nitrone 2a (Table 2, Entry 2): To 
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a CHCl3 (3 ml) solution of (R,R)-DTBT (157 mg, 0.6 
mmol) was added dimethylzinc (1.55 ml of 1.0 M solution 
in hexane, 1.55 mmol) at 0 °C under argon atmosphere, and 
the mixture was stirred for 10 min.  To the solution, a 
CHCl3 (3 ml) solution of racemic N-benzyl-N-[1-(4-
methoxyphenyl)-3-phenylprop-2-ynyl]hydroxylamine (34 
mg, 0.1 mmol) was added. After stirring for 10 min,
diphenylzinc (1.95 ml of 0.128 M solution in toluene, 0.25
mmol) was added to the solution. The reaction mixture 
was warmed to 25 ºC and stirred for 1 h, then a CHCl3 (3 
ml) solution of the nitrone 2a (117 mg, 0.5 mmol) was 
added.  The resulting solution was stirred at 25 ºC for 1 h
and quenched by addition of a saturated aq. NH4Cl solution.  
After filtration of the precipitate, the filtrate was extracted 
with AcOEt.  The combined extracts were washed with 
brine, dried over Na2SO4, and condensed under reduced 
pressure.  The residue was separated by TLC on SiO2 to 
isolate 3a (hexane/AcOEt = 3/1) in 75% yield (117 mg).
(S)-N-Benzyl-N-(1,3-diphenylprop-2-ynyl)hydrox
ylamine (3a):10  Mp 133–134 °C (from EtOH); []D25 –42
(c 1.23, EtOH, 92% ee); IR (KBr) 3239, 3029, 2905, 1597, 
1488, 1452, 1331, 1298, 1179, 1070, 1026, 1003, 988, 916, 
826, 812, 757, 729, 690 cm–1; 1H NMR (CDCl3):  = 3.89
(d, J = 12.69 Hz, 1H, CH2Ph), 3.99 (d, J = 12.69 Hz, 1H, 
CH2Ph), 4.87 (s, 1H, ArCHNBn), 5.69 (s, 1H, OH), 7.28-
7.37 (m, 10H), 7.59-7.61 (m, 5H). Found: C, 84.31; H, 
6.15; N, 4.43%. Calcd for C22H19NO: C, 84.31; H, 6.11; N, 
4.47%.  The enantiomer ratio was determined by HPLC 
analysis (Daicel Chiralcel OD-H, hexane/iPrOH = 45/1, 
detected at 254 nm).
(S)-N-Benzyl-N-(1-phenyl-3-p-tolylprop-2-ynyl) hydrox
ylamine (3b):  Mp 135–136 °C (from EtOH); []D25 –45 (c 
1.23, EtOH, 87% ee); IR (KBr) 3236, 3028, 2918, 1600, 
1542, 1508, 1495, 1453, 1353, 1289, 1075, 1029, 1020, 985, 
913, 861, 815, 757, 738, 696 cm–1; 1H NMR (CDCl3):  = 
2.37 (s, 3H, CH3), 3.99 (s, 2H, CH2Ph), 4.93 (s, 1H, 
ArCHNBn), 5.25 (s, 1H, OH), 6.87-7.86 (m, 14H). Found: 
C, 84.09; H, 6.50; N, 4.34%. Calcd for C23H21NO: C, 
84.37; H, 6.47; N, 4.28%.  The enantiomer ratio was 
determined by HPLC analysis (Daicel Chiralcel OD-H, 
hexane/iPrOH = 60/1, detected at 254 nm).
(S)-N-Benzyl-N-[3-(4-bromophenyl)-1-phenylprop-2-
ynyl]hydroxylamine (3c):  Mp 166-167 °C (from EtOH); 
[]D25 –69 (c 0.50, EtOH, 90% ee); IR (KBr) 3339, 3063, 
3030, 2971, 2894, 1602, 1485, 1453, 1393, 1297, 1272, 
1070, 1049, 1011, 880, 824, 736, 699 cm–1; 1H NMR 
(CDCl3):  = 3.98 (d, J = 13.17 Hz, 1H, CH2Ph), 4.06 (d, J
= 13.17 Hz, 1H, CH2Ph), 4.98 (s, 1H, ArCHNBn), 5.05 (s, 
1H, OH), 7.28-7.49 (m, 12H), 7.57-7.63 (m, 2H). Found: C, 
67.51; H, 4.70; N, 3.52%. Calcd for C22H18NOBr: C, 67.35; 
H, 4.60; N, 3.57%.  The enantiomer ratio was determined 
by HPLC analysis (Daicel Chiralcel OD-H, hexane/iPrOH
= 45/1, detected at 254 nm).
(S)-N-Benzyl-N-(1-phenylnon-2-ynyl)hydroxylamine
(3d):  An oil, []D25 –43 (c 1.14, EtOH, 87% ee); IR (neat) 
3256, 3086, 3063, 3030, 2930, 2857, 2227, 1603, 1585, 
1558, 1494, 1454, 1330, 1180, 1074, 1050, 879, 831, 813, 
755, 735, 699 cm–1; 1H NMR (CDCl3):  = 0.90 (t, J = 6.69
Hz, 3H, CH3), 1.23-1.35 (m, 4H, (CH2)2), 1.43-1.51 (m, 2H, 
CH2), 1.58-1.74 (m, 2H, CH2), 2.38 (t, J = 5.04 Hz, 2H, 
C≡CCH2), 3.90 (d, J = 13.11 Hz, 1H, CH2Ph), 4.00 (d, J = 
13.11 Hz, 1H, CH2Ph), 4.77 (s, 1H, ArCHNBn), 4.89 (s, 
1H, OH), 7.14-7.39 (m, 8H), 7.52-7.58 (m, 2H); HRMS 
(FAB+), Found: m/z 322.21737. Calcd for C22H28NO: (M
+ +
H), 322.21709. The enantiomer ratio was determined by 
HPLC analysis (Daicel Chiralcel OD-H, hexane/EtOH = 
75/1, detected at 254 nm).
Asymmetric Phenylation of (Z)-1-Phenyl-N-[(E)-3-
phenylallylidene]methanamine Oxide (5) (Eq. 3):  To a 
CH2Cl2 (1.8 ml) solution of (R,R)-DTBT (95 mg, 0.36
mmol) was added dimethylzinc (0.78 ml of 1.0 M solution 
in hexane, 0.78 mmol) at 0 °C under argon atmosphere, and 
the mixture was stirred for 10 min.  To the solution, a 
CH2Cl2 (1.8 ml) solution of racemic N-
benzyl-N-[1-(4-methoxyphenyl)-3-phenylprop-2-ynyl]hydr
oxylamine (21 mg, 0.06 mmol) was added.  After stirring 
for 10 min, diphenylzinc (2.3 ml of 0.129 M solution in 
toluene, 0.30 mmol) was added to the solution.  Then a 
CH2Cl2 (1.8 ml) solution of the nitrone 5 (72 mg, 0.30
mmol) was added.  The resulting solution was stirred at 25 
ºC for 24 h and quenched by addition of a saturated aq. 
NaHCO3 solution.  After filtration of the precipitate, the 
filtrate was extracted with AcOEt.  The combined extracts 
were washed with brine, dried over Na2SO4, and condensed 
under reduced pressure.  The residue was separated by TLC 
on SiO2 to isolate 6 (hexane/AcOEt = 10/1) in 76% yield 
(73 mg).
(R,E)-N-Benzyl-N-(1,3-diphenylallyl)hydroxylamine (6): 
An oil, []D25 +7 (c 0.73, EtOH, 49% ee); IR (neat) 3529, 
3082, 3059, 3027, 2923, 2850, 1599, 1494, 1452, 1246, 
1072, 1028, 966, 744, 697 cm–1; 1H NMR (CDCl3):  = 
3.81 (d, J = 13.42 Hz, 1H, CH2Ph), 3.95 (d, J = 13.42 Hz,
1H, CH2Ph), 4.44 (d, J = 8.04 Hz, 1H), 4.75 (s, 1H, OH), 
6.54 (m, 1H), 6.65 (d, J = 11.20 Hz, 1H), 7.27-7.58 (m, 
15H); HRMS (FAB+), Found: m/z 316.16955. Calcd for 
C22H22NO: (M
+ + H), 316.17014.  The enantiomeric ratio
was determined by HPLC analysis (Daicel Chiralcel OD-H, 
hexane/iPrOH = 20/1, detected at 254 nm).
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Stereochemistry Abstract








Ee = 92% 
[]D25 42 (c 1.23, EtOH)
Source of chirality: (R,R)-DTBT
Absolute configuration: (S)








Ee = 87% 
[]D25 45 (c 1.23, EtOH)
Source of chirality: (R,R)-DTBT
Absolute configuration: (S)








Ee = 90% 
[]D25 69 (c 0.50, EtOH)
Source of chirality: (R,R)-DTBT
Absolute configuration: (S)







Ee = 87% 
[]D25 43 (c 1.14, EtOH)
Source of chirality: (R,R)-DTBT
Absolute configuration: (S)








Ee = 49% 
[]D25 +7 (c 0.73, EtOH)
Source of chirality: (R,R)-DTBT
Absolute configuration: (R)
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